Back to Stakeholders
Categories

3 domains / 5 areas / 4 specializations

Research, Drug Development & Manufacturing
Academic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & Manufacturing
Government, Policy & Advocacy
Government, Policy & Advocacy
Policy Advocacy & ReformDrug Policy Reform OrganizationsThink Tanks
Media, Education & Engagement
Educational Platforms & ResourcesOnline Resources

Drug Science

Also known as: Drug Science UK, Drug Science

Data updated

London, United Kingdom, United Kingdom

Drug Science is a UK-based independent, science-led drugs charity founded in 2010 and headquartered in London, with work aimed at the UK public and international audiences. It focuses on building an evidence base for drug harms and benefits, and on equipping the public, media, and policymakers with scientific information to support sensible drug laws and evidence-based debate.

In psychedelics, Drug Science is an explicit field actor rather than a peripheral observer. Its Medical Psychedelics Working Group promotes evidence-based psychedelic research and access, including support for removing psychedelic drugs from Schedule 1 restrictions, improving regulatory pathways for medical use, and producing educational resources for healthcare professionals and the public. The organization also publishes commentary and research-led content on psychedelic policy, clinical development, and public attitudes, and has recent documented activity around psilocybin regulation, psychedelic terminology, and UK research ecosystem updates.

ProfessionalHybridPremiumAcademic programmeContinuing educationAspiring practitionersLicensed cliniciansResearchersOther

Blossom’s read

Drug Science is best understood as an evidence-led UK drugs charity whose psychedelic work sits at the research, policy and practitioner-education end of the field, rather than as a commercial retreat school. Its standing comes from its scientific committee, public-health framing and clear connection to figures such as Prof David Nutt, with the Medical Psychedelics Working Group and PsyEdu course line giving it a credible institutional footprint. It is most suitable for health and social care professionals, researchers and adjacent practitioners who want a serious, science-first introduction or professional refresher rather than an experiential or spiritually framed programme.

Who is Drug Science for?

Best for registered health and social care professionals, plus experienced complementary practitioners and other adjacent professionals who want evidence-based psychedelic literacy for practice, research or policy. It also suits curious public learners who want a shorter introductory course, especially outside a clinical credential route.

What do you need before you start?

For the Professional Certificate in Psychedelic Practice, Drug Science states the course is aimed at people already working in professional practice, especially registered Health and Social Care professionals or complementary practitioners with at least two years' experience. It also says admission for applicants outside the standard criteria is at the discretion of the PsyEdu Academic Director.

Is Drug Science accredited?

Drug Science describes its training hub as offering audited and Drug Science accredited psychedelic training programmes worldwide. The UK certificate is presented as a Level 6 postgraduate programme, and the Australia course offers a Certificate of Completion plus 15 CPD hours, but Drug Science does not present itself as a statutory accreditor or licensing body.

How much does it cost?

The UK Professional Certificate in Psychedelic Practice lists a standard fee of £5,500, with early-bird pricing of £5,150 and super early bird pricing of £4,750. It also offers instalment payments and says bursaries are available, while the Australia course is listed at £315.

What do you walk away with?

Learners can expect a professional certificate, structured training in psychedelic science and practice, and a network pathway into areas such as clinical psychedelic trials, preparation and integration work, retreat support and ketamine-assisted psychotherapy. Drug Science also frames its courses as building theoretical, practical and reflective competence for working with people who use psychedelic medicines.

Academic Research

0 papers

Published Papers

0

Trial Involvement

0

Distinct Focus Topics

0

Latest Publication

Unknown

Similar course providers

Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.

MIND Foundation
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: hybrid delivery
Synthesis
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: hybrid delivery
Clerkenwell Health
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: hybrid delivery
Mind Medicine Australia
  • Strong match: 2 shared modalities
  • Strong match: 3 shared learner audiences
  • Also shares: professional level
  • Also shares: hybrid delivery

Quick Facts

Founded
2010
HQ
London, United Kingdom, United Kingdom
Website
Visit